Passage Bio Inc’s filing revealed that its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $83298.0 on Jan 10 ’25. In the deal valued at $0.66 per share,126,209 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 7,131,636 shares worth roughly $4.28 million.
Then, ORBIMED ADVISORS LLC sold 79,024 shares, generating $47,414 in total proceeds. Upon selling the shares at $0.60, the 10% Owner now owns 7,034,626 shares.
Before that, ORBIMED ADVISORS LLC sold 17,986 shares. Passage Bio Inc shares valued at $11,511 were divested by the 10% Owner at a price of $0.64 per share. As a result of the transaction, ORBIMED ADVISORS LLC now holds 7,113,650 shares, worth roughly $4.27 million.
A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. JP Morgan also remained covering PASG and has decreased its forecast on March 08, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. Goldman revised its rating on January 19, 2022. It rated PASG as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PASG
On Friday, Passage Bio Inc [NASDAQ:PASG] saw its stock unchanged to $0.60. Over the last five days, the stock has lost -10.45%. Passage Bio Inc shares have risen nearly 5.80% since the year began. Nevertheless, the stocks have fallen -34.79% over the past one year. While a 52-week high of $1.79 was reached on 01/02/25, a 52-week low of $0.45 was recorded on 01/16/25. SMA at 50 days reached $0.6777, while 200 days put it at $0.8725.
Levels Of Support And Resistance For PASG Stock
The 24-hour chart illustrates a support level at 0.5815, which if violated will result in even more drops to 0.5629. On the upside, there is a resistance level at 0.6243. A further resistance level may holdings at 0.6485. The Relative Strength Index (RSI) on the 14-day chart is 43.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0738, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.23%. Stochastics %K at 7.20% indicates the stock is a buying.
How much short interest is there in Passage Bio Inc?
A steep rise in short interest was recorded in Passage Bio Inc stocks on 2024-10-31, dropping by 59917.0 shares to a total of 1.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.7 million shares. There was a decline of -3.65%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 01, 2021 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $29 price target.
